Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
Primary myelofibrosis (PMF) is a chronic myeloproliferative disorder seen in older adults which can present both with hepatosplenomegaly as well as mild nonspecific liver enzyme abnormalities. Mild elevations in bilirubin can occasionally be seen due to both intravascular hemolysis as well as extram...
Saved in:
| Main Authors: | Sunny Sandhu, Hunza Chaudhry, Sharon Zhang, Devang Prajapati |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2022/9630996 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemostasis in patients with primary myelofibrosis treated with ruxolitinib
by: O. G. Golovina, et al.
Published: (2024-11-01) -
PREDICTORS OF RESPONSE TO RUXOLITINIB THERAPY IN PATIENTS WITH MYELOFIBROSIS
by: Irina Turtanova, et al.
Published: (2025-07-01) -
Tuberculosis reactivation related with ruxolitinib in a patient with primary myelofibrosis
by: Mehmet S Pepeler, et al.
Published: (2018-10-01) -
Melanoma during Ruxolitinib Treatment for Myelofibrosis
by: Lingzhi Zhong, et al.
Published: (2025-07-01) -
Myelofibrosis: Treatment Options After Ruxolitinib Failure
by: Ruth Stuckey, et al.
Published: (2025-06-01)